Lv7
4420 积分 2020-12-21 加入
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
28天前
已完结
Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer
1个月前
已完结
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
1个月前
已完结
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
1个月前
已完结
Evolution of claudin18.2 therapies in gastroesophageal cancers
1个月前
已完结
[Expert consensus on Claudin18.2 expression testing in gastric cancer (2025 version)]
1个月前
已完结
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma
3个月前
已完结
Biliary Tract Cancers
3个月前
已完结
Portal hemodynamic effects of lenvatinib in patients with advanced hepatocellular carcinoma: A prospective cohort study
5个月前
已完结
Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study
5个月前
已完结
皖公网安备34019202002308
